Central Nervous System Pseudoprogression in a Patient Treated with PD-1 Checkpoint Inhibitor

J Thorac Oncol. 2015 Oct;10(10):e100-1. doi: 10.1097/JTO.0000000000000587.

Authors

Mark K Doherty¹, Kevin Jao, Frances A Shepherd, Lili-Naz Hazrati, Natasha B Leighl

Affiliation

¹ *Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada; and †Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

PMID: 26398825
DOI: 10.1097/JTO.0000000000000587

No abstract available

Publication types

Case Reports

MeSH terms

Adenocarcinoma / drug therapy*
Adenocarcinoma / pathology*
Adenocarcinoma of Lung
Disease Progression
Humans
Lung Neoplasms / drug therapy*
Lung Neoplasms / pathology*
Male
Middle Aged
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
Programmed Cell Death 1 Receptor / metabolism
Treatment Outcome

Substances

Programmed Cell Death 1 Receptor